The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

Fund Price: $6.10 (as at May 17, 2013)  1-week chg:  0.83%  YTD: 9.91%

Returns as at April 30, 2013

  Fund Group Avg Index*
1 Month -0.49% -0.71% -4.81%
3 Months -1.78% -2.63% -6.51%
6 Months 3.58% -8.75% -4.44%
1 Year 3.58% -13.63% -5.19%
2 Year Avg -0.89% -11.54% -9.58%
3 Year Avg -2.65% -8.69% 1.69%
4 Year Avg -1.92% -7.20% 15.90%
5 Year Avg -3.46% -8.33% 2.66%
10 Year Avg - -1.71% 10.16%
15 Year Avg - -1.04% 6.34%
20 Year Avg - -1.91% 8.19%
Since Inception -3.77% - -
 
2012 -8.42% -10.29% 2.46%
2011 -4.27% -7.14% -14.17%
2010 -1.40% 2.86% 38.53%
 
3 year risk 9.30 10.62 16.63
3 year beta -0.07 0.06 1.00

*BMO Nesbitt Burns Cdn Small Cap Index

Growth of $10,000

This graph shows how a $10,000 investment in this fund would have changed in value compared with the BMO Nesbitt Burns Cdn Small Cap Index.

Risk Measures as at April 30, 2013

Best/Worst 12 months (since inception)
Best (ending Jun 07): 5.56 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
Worst (ending Mar 05): -12.46 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
Volatility meter (Based on 3 year standard deviation from GlobeInvestor.com)
Low VOLATILITY METER: 9 High

Fund Objectives

The investment objective of the Fund is to obtain long term capital growth which means the Fund tries to provide investors with a return on their investment by increasing the NAV of the Shares over time, rather than by regularly paying out interest or dividends. The Venture Series Shares' Primary Funds are invested in a diversified portfolio of Eligible Business Investments. The Fund's objective is to diversify that portfolio by business sector, with major groupings being in advanced manufacturing, life sciences and information technology, and by stage of company development.

Fund Facts

Fund Sponsor: GrowthWorks Managed Funds
Managed by: GrowthWorks Managed Funds
Fund Type: MF Corp
Inception Date: January 2004
Asset Class: Retail Venture Capital
Quartile Rank: 2 (3YR ending April 30, 2013)
Total Assets: $88.6 million
Mgmt Exp. Ratio (MER): 2.90%
Management Fee: 2.00%
Load Type: Both
Globe 5-Star Rating:
RRSP Eligible:
Canadian
Min. Invest (initial):
$500
Subsequent:
$25
Min. Invest (initial RRSP):
$500
Subsequent RRSP:
$25
Closed:
No
Restricted:
Yes
Restriction:
Not Available in AL,SA,MA,ON,PQ,NB,NS,NF,PEI,YK,NWT,NUV
 
 

Asset Allocation April 30, 2007

Equity Sector Weightings April 30, 2007

Fund Geography April 30, 2007

Top Holdings as at April 30, 2007

Symbol Company Name Sector Geographic
Area		 Asset
Type		 % of
Total Assets		   Performance as at May 17, 2013
1 Year Performance (%)
AVP-T Avcorp Industries - Canada Stock -   20.0 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
- Xantrex Technology Inc. - Canada Stock -   - bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
- Cellfor Inc. - Canada Stock -   - bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
- Protiva Biotherapeutics Other Canada Stock -   - bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
- Neuromed Technologies Inc. - Canada Stock -   - bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
- Teradici Corp. - Canada Stock -   - bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
- Celator Pharmaceuticals Inc. - Canada Stock -   - bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
- Xenon Pharmaceuticals Inc. - Canada Stock -   - bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
- Bycast Inc. - Canada Stock -   - bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
- Twinstrand Therapeutics Inc. - Canada Stock -   - bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)

Portfolio Manager(s)

GrowthWorks Capital - Mgmt. Team

GrowthWorks Capital Ltd.

Start Date: January, 2004

Fund Return: -2.91%

GrowthWorks Capital Ltd., is a fund management company with proven expertise in raising and investing capital. GrowthWorks strives to successfully invest equity capital in and provide practical business advice to ethical, innovative, rapidly growing, entrepreneurial companies.

Also manages:GrowthWorks Canadian, GrowthWorks Cdn Diversified I, GrowthWorks Cdn Financial I, GrowthWorks Cdn Growth I, GrowthWorks Cdn Income I, GrowthWorks Commercialization 505, Working Opp Commercialization 10, Working Opp Commercialization 11, Working Opport Commercialization 05, Working Opportunity Cl A GIC Sh Srs, Working Opportunity Commercial 12, Working Opportunity Financial, Working Opportunity Growth Ser 1

View fund manager performance report